相似文献
1
Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.
J Clin Microbiol. 2009 Apr;47(4):1252-4. doi: 10.1128/JCM.02052-08. Epub 2009 Feb 4.
2
A case of EBV driven haemophagocytic lymphohistiocytosis complicating a teenage Crohn's disease patient on azathioprine, successfully treated with rituximab.
J Crohns Colitis. 2013 May;7(4):314-7. doi: 10.1016/j.crohns.2012.05.002. Epub 2012 May 27.
3
Epstein-Barr virus related lymphoma in inflammatory bowel disease.
Acta Gastroenterol Belg. 2008 Jan-Mar;71(1):33-5.
4
[Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1859-63.
5
[Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease].
Gastroenterol Hepatol. 2000 Jan;23(1):7-8.
6
Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.
Gut. 1995 Feb;36(2):311-3. doi: 10.1136/gut.36.2.311.
7
Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
J Pediatr Gastroenterol Nutr. 2008 Aug;47(2):193-5. doi: 10.1097/MPG.0b013e31816a30b9.
8
Primary EBV infection resulting in lymphoproliferative disease in a teenager with Crohn disease.
J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):103-5. doi: 10.1097/MPG.0b013e3181e80410.
9
Epstein-Barr virus-associated lymphoma in Crohn's disease.
Inflamm Bowel Dis. 2004 Jul;10(4):425-9. doi: 10.1097/00054725-200407000-00015.
10
Immunomodulator-associated Epstein-Barr virus-positive mucocutaneous ulcer in a patient with refractory Crohn's disease.
Clin J Gastroenterol. 2019 Aug;12(4):330-335. doi: 10.1007/s12328-019-00952-4. Epub 2019 Mar 22.
引用本文的文献
1
Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
Front Immunol. 2022 Oct 28;13:1001055. doi: 10.3389/fimmu.2022.1001055. eCollection 2022.
2
Immunomodulators: still having a role?
Gastroenterol Rep (Oxf). 2022 Nov 8;10:goac061. doi: 10.1093/gastro/goac061. eCollection 2022.
3
Viral infections in inflammatory bowel disease: Tips and tricks for correct management.
World J Gastroenterol. 2021 Jul 21;27(27):4276-4297. doi: 10.3748/wjg.v27.i27.4276.
4
Use of thiopurines in inflammatory bowel disease: an update.
Intest Res. 2022 Jan;20(1):11-30. doi: 10.5217/ir.2020.00155. Epub 2021 Apr 15.
5
Hemophagocytic Lymphohistiocytosis and Inflammatory Bowel Disease: Case Report and Systematic Review.
Inflamm Intest Dis. 2020 Jun;5(2):49-58. doi: 10.1159/000506514. Epub 2020 Mar 10.
6
A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
BMC Infect Dis. 2019 May 10;19(1):404. doi: 10.1186/s12879-019-4022-3.
7
Epstein-Barr virus-associated hemophagocytic syndrome in a patient with ulcerative colitis during treatment with azathioprine: A case report and review of literature.
World J Clin Cases. 2018 Nov 26;6(14):776-780. doi: 10.12998/wjcc.v6.i14.776.
8
Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
Curr Gastroenterol Rep. 2018 Sep 28;20(11):53. doi: 10.1007/s11894-018-0658-1.
9
Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disorders.
World J Gastrointest Pathophysiol. 2015 Nov 15;6(4):181-92. doi: 10.4291/wjgp.v6.i4.181.
10
Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection.
Prz Gastroenterol. 2015;10(2):78-82. doi: 10.5114/pg.2015.48995. Epub 2015 Oct 2.
本文引用的文献
1
Epstein-Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients.
Curr Opin Hematol. 2008 Nov;15(6):576-85. doi: 10.1097/MOH.0b013e328311f438.
2
Simultaneous manifestation of fulminant infectious mononucleosis with haemophagocytic syndrome and B-cell lymphoma in X-linked lymphoproliferative disease.
Eur J Pediatr. 2007 Jun;166(6):589-93. doi: 10.1007/s00431-006-0290-1. Epub 2006 Oct 21.
3
[Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease].
Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1859-63.
4
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine.
Gut. 2005 Aug;54(8):1121-5. doi: 10.1136/gut.2004.049460.
5
Epstein-Barr virus-associated lymphoma in Crohn's disease.
Inflamm Bowel Dis. 2004 Jul;10(4):425-9. doi: 10.1097/00054725-200407000-00015.
6
Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature.
Leuk Lymphoma. 2003 Jul;44(7):1215-21. doi: 10.1080/1042819031000079221.
7
Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Crit Rev Oncol Hematol. 2002 Dec;44(3):259-72. doi: 10.1016/s1040-8428(02)00117-8.
8
Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis.
Arch Intern Med. 2002 Apr 8;162(7):837-9. doi: 10.1001/archinte.162.7.837.
9
Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine.
Gastroenterology. 2002 Jan;122(1):72-7. doi: 10.1053/gast.2002.30328.
10
The new World Health Organization classification of lymphomas: the past, the present and the future.
Hematol Oncol. 2001 Dec;19(4):129-50. doi: 10.1002/hon.660.
Zotero 插件